Tissue Necrosis Analysis
Tissue Necrosis Analysis - Related Videos
01:16
Necrosis
0 Views •
2023
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”. Morphological Manifestations of Necrosis Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
02:12
Muscle Necrosis Assay in C. elegans Induced by a Pathogenic Aeromonas Strain
0 Views •
2026
Source: Chen, Y. et. al., Evaluating Virulence and Pathogenesis of Aeromonas Infection in a Caenorhabditis elegans Model. J. Vis. Exp. (2018)This video demonstrates a muscle necrosis assay in C. elegans (Caenorhabditis elegans) using pathogenic Aeromonas strains. By feeding green fluorescent protein (GFP)-expressing worms on Aeromonas-seeded plates, the assay models bacterial infection and reveals tissue damage through fluorescence imaging. The progressive loss of muscle structure and GFP...
01:16
Cellular Injury IV: Necrosis
0 Views •
2026
Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...
04:37
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
0 Views •
Cited by 1 •
2025
The present protocol provides a comprehensive set of procedures necessary to analyze procoagulant platelets, which exhibit overlapping features of necrosis, apoptosis, and platelet activation.
11:24
High-throughput Imaging and Analysis Workflow for Evaluating Skin Cell Phenotypes and Proliferation States in Tissue Samples
0 Views •
Cited by 1 •
2025
The combination of iterative-bleaching-extends-multiplexity (IBEX) and a commercial nucleotide labeling assay (Click-iT EdU) enables the detection and categorization of dividing cell types in highly dynamic processes in fixed frozen murine tissue sections. Furthermore, a novel open-source image processing pipeline provides high-throughput image acquisition and analysis.
FAQs
Membrane failure allows necrotic cells to swell and release intracellular contents into surrounding tissue. These released contents can trigger inflammation, linking cellular injury to changes in the local tissue environment. Assessing both the cellular damage and the associated inflammatory response helps characterize the injury rather than treating necrosis as an isolated microscopic finding.
Interpretation focuses on the extent and characteristics of tissue damage, along with its likely consequences. Analysts examine changes associated with membrane disruption, cellular swelling, intracellular release, and surrounding inflammation. This combination helps determine how broadly injury has developed and supports assessment of whether affected tissue is irreversibly damaged or still potentially viable.
The distinction influences how clinicians interpret the severity and consequences of an injury. Tissue necrosis analysis can help separate areas that have sustained irreversible damage from tissue that may remain viable, supporting more informed clinical decision-making. This distinction is particularly relevant when evaluating ischemia, trauma, infection, tumors, or injury caused by treatment.
A systematic assessment may combine histopathology, microscopy, imaging, and selected biochemical markers. Histopathology and microscopy help identify cellular and tissue changes, while imaging contributes information about affected regions, and biochemical markers provide additional evidence of injury. Using these approaches together supports characterization of extent, cellular features, and potential consequences.
Medical applications include evaluating tissue injury associated with ischemia, infection, trauma, tumors, and treatment-related damage. The analysis can support diagnosis and disease-severity assessment across these settings. It also provides a way to monitor treatment response, helping clinicians and researchers determine whether observed tissue changes are consistent with progression, injury, or response to intervention.
Results can help estimate disease severity, monitor treatment response, and guide clinical decision-making. In research, the same information contributes to studies of disease mechanisms and tissue repair. By documenting the extent and characteristics of necrotic injury, investigators can examine how damage develops and evaluate questions related to recovery or persistent tissue loss.